Kansas SB 376: Instituting a $100 maximum out-of-pocket cost-share per month per covered person for prescription insulin drugs.

Status: Died in Committee (as of 2020-05-21)

State: Kansas · Session: 2019-2020 · Bill: SB 376

Sponsors: Committee on Assessment and Taxation

View Kansas SB 376 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.